Endocrinology Diabetes and Metabolism Case Reports

Scope & Guideline

Empowering Research with Open Access Discoveries

Introduction

Explore the comprehensive scope of Endocrinology Diabetes and Metabolism Case Reports through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Endocrinology Diabetes and Metabolism Case Reports in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherBIOSCIENTIFICA LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationENDOCR DIAB MET C R / Endocrinol. Diabetes Metab. Case Rep.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL BS34 8YU, ENGLAND

Aims and Scopes

The journal 'Endocrinology Diabetes and Metabolism Case Reports' focuses on the intricate relationship between endocrinology, diabetes, and metabolic disorders through case reports. It aims to provide a platform for sharing unique clinical experiences that contribute to the understanding and management of endocrine and metabolic diseases.
  1. Clinical Insights into Endocrine Disorders:
    The journal emphasizes case reports that provide insights into the diagnosis, treatment, and management of various endocrine disorders, including thyroid diseases, adrenal dysfunction, and pituitary tumors.
  2. Diabetes Management and Complications:
    A significant focus is on the complexities of diabetes management, including the presentation of diabetes-related complications, innovative treatments, and the interplay between diabetes and other metabolic or endocrine disorders.
  3. Rare and Complex Cases:
    The journal highlights rare and complex cases that contribute to the body of knowledge in endocrinology and diabetes, often presenting unique challenges in diagnosis and treatment.
  4. Interdisciplinary Approaches:
    The publication encourages interdisciplinary approaches to managing endocrine and metabolic disorders, emphasizing collaboration between endocrinologists, cardiologists, oncologists, and other specialists.
  5. Emerging Therapeutic Strategies:
    The journal discusses emerging therapeutic strategies and case-based evidence that may influence clinical practice, particularly in the management of diabetes and endocrine disorders.
The journal has seen a rise in interest in several trending and emerging themes reflecting current challenges and advancements in the field of endocrinology, diabetes, and metabolism.
  1. Impact of COVID-19 on Endocrine Disorders:
    Recent publications indicate a growing focus on the impact of COVID-19 on endocrine disorders, including new-onset diabetes and complications related to viral infections and vaccinations.
  2. Case Studies on Rare Genetic Disorders:
    There is an increasing trend in case reports addressing rare genetic and hereditary disorders linked to endocrine dysfunction, highlighting the importance of genetic testing and personalized approaches in management.
  3. Innovative Management Strategies for Diabetes:
    The emergence of innovative management strategies for diabetes, including dietary interventions and new pharmacological treatments, has become a prominent theme in recent publications.
  4. Autoimmune and Paraneoplastic Endocrine Syndromes:
    The journal is increasingly publishing cases related to autoimmune and paraneoplastic syndromes, reflecting a deeper exploration of the immune system's role in endocrine disorders.
  5. Integration of Telemedicine in Endocrinology:
    There is a rising interest in the use of telemedicine for managing endocrine disorders, particularly highlighted by case studies that demonstrate its effectiveness in patient care during the pandemic.

Declining or Waning

In contrast to its emerging themes, certain scopes within the journal seem to be declining in prominence over recent years. This reflects shifts in clinical focus and research priorities in the field of endocrinology and diabetes.
  1. Traditional Treatment Modalities:
    There appears to be a waning emphasis on traditional treatments for diabetes and endocrine disorders, as newer therapeutic strategies and personalized medicine approaches gain more attention in case reports.
  2. Generalized Case Reports Without Novel Insights:
    The journal seems to be moving away from publishing generalized case reports that do not offer unique insights or novel findings, focusing instead on cases that provide significant contributions to clinical knowledge.
  3. Non-Endocrine Related Metabolic Disorders:
    There is a noticeable decrease in case reports focused exclusively on non-endocrine related metabolic disorders, as the journal narrows its scope to more closely align with endocrine and diabetes-related cases.

Similar Journals

Annals of Pediatric Endocrinology & Metabolism

Empowering researchers to transform pediatric health.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Exploring breakthroughs in metabolic health.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Connecting disciplines in endocrine and metabolic advancements.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Journal of Endocrinology and Metabolism

Advancing knowledge in endocrine health and metabolic science.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

Endocrine Practice

Exploring the Frontiers of Diabetes and Metabolism
Publisher: ELSEVIER INCISSN: 1530-891XFrequency: 12 issues/year

Endocrine Practice is a premier journal dedicated to the dynamic and evolving field of endocrinology, published by Elsevier Inc.. With a significant emphasis on clinical practice, research, and advancements in the multidisciplinary domains of endocrinology, diabetes, and metabolism, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. As a recognized leader in its field, it boasts an impressive impact factor and is ranked in the Q1 quartile for both Endocrinology and Medicine categories, reflecting its high-quality research contributions and relevance to contemporary clinical practice. The journal enjoys a robust reputation, achieving Scopus rankings with a placement of #57 out of 244 in Endocrinology, Diabetes and Metabolism, and #37 out of 128 in Biochemistry, Genetics and Molecular Biology. Although it is not available as open access, Endocrine Practice continues to disseminate critical findings from 2000 through to 2024, ensuring that professionals remain at the forefront of endocrine research and clinical application.

HORMONE AND METABOLIC RESEARCH

Driving Innovation in Endocrine and Metabolic Studies
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

ENDOCRINE JOURNAL

Innovating insights for a healthier endocrine future.
Publisher: JAPAN ENDOCRINE SOCISSN: 0918-8959Frequency: 12 issues/year

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Exploring Innovations in Endocrine Science
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Frontiers in Endocrinology

Advancing Knowledge in Endocrinology and Metabolism
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Nature Reviews Endocrinology

Navigating the complexities of hormonal functions.
Publisher: NATURE PORTFOLIOISSN: 1759-5029Frequency: 12 issues/year

Nature Reviews Endocrinology is a premier journal published by NATURE PORTFOLIO, providing comprehensive and critical reviews in the rapidly evolving field of endocrinology. Established to foster advanced understanding, it has become a vital resource for researchers, professionals, and students alike. With an impressive impact factor and a prominent ranking of Q1 in both Endocrinology and Endocrinology, Diabetes, and Metabolism categories for 2023, the journal is recognized for its high-quality research dissemination, evidenced by its rankings of #2 out of 244 in Medicine and #2 out of 128 in Biochemistry, Genetics, and Molecular Biology. Spanning the years from 2009 to 2024, it focuses on publishing cutting-edge information that shapes current scientific knowledge and clinical practices. The journal offers open access options, ensuring greater visibility and reach for its articles. Located in Germany, this journal remains at the forefront of endocrinology research, significantly contributing to the understanding of hormonal functions and their implications on health. Discover the latest advancements and insights by exploring Nature Reviews Endocrinology.